Current and historical daily PE Ratio for Realcan Pharmaceutical Group Co Ltd (
SZSE:002589
) from 2011 to May 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Realcan Pharmaceutical Group stock (SZSE:002589) PE ratio as of May 22 2024 is 293.33.
More Details
Realcan Pharmaceutical Group Co Ltd (SZSE:002589) PE Ratio (TTM) Chart
Realcan Pharmaceutical Group Co Ltd (SZSE:002589) PE Ratio (TTM) Historical Data
View and export this data going back to 2011. Start your Free Trial
Total 1189
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Realcan Pharmaceutical Group PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-23 | 293.3 | 2024-03-14 | 206.2 |
| 2024-05-22 | 303.3 | 2024-03-13 | 206.2 |
| 2024-05-21 | 302.2 | 2024-03-12 | 210.0 |
| 2024-05-20 | 306.7 | 2024-03-11 | 203.8 |
| 2024-05-17 | 308.9 | 2024-03-08 | 196.9 |
| 2024-05-16 | 307.8 | 2024-03-07 | 196.9 |
| 2024-05-15 | 310.0 | 2024-03-06 | 199.2 |
| 2024-05-14 | 311.1 | 2024-03-05 | 200.0 |
| 2024-05-13 | 306.7 | 2024-03-04 | 203.8 |
| 2024-05-10 | 315.6 | 2024-03-01 | 201.5 |
| 2024-05-09 | 321.1 | 2024-02-29 | 199.2 |
| 2024-05-08 | 322.2 | 2024-02-28 | 194.6 |
| 2024-05-07 | 326.7 | 2024-02-27 | 206.9 |
| 2024-05-06 | 320.0 | 2024-02-26 | 202.3 |
| 2024-04-30 | 297.8 | 2024-02-23 | 200.0 |
| 2024-04-29 | 297.8 | 2024-02-22 | 194.6 |
| 2024-04-26 | 280.0 | 2024-02-21 | 191.5 |
| 2024-04-25 | 280.0 | 2024-02-20 | 187.7 |
| 2024-04-24 | 274.4 | 2024-02-19 | 186.2 |
| 2024-04-23 | 272.2 | 2024-02-08 | 180.8 |
| 2024-04-22 | 266.7 | 2024-02-07 | 168.5 |
| 2024-04-19 | 272.2 | 2024-02-06 | 175.4 |
| 2024-04-18 | 274.4 | 2024-02-05 | 172.3 |
| 2024-04-17 | 283.3 | 2024-02-02 | 191.5 |
| 2024-04-16 | 266.7 | 2024-02-01 | 198.5 |
| 2024-04-15 | 292.2 | 2024-01-31 | 206.2 |
| 2024-04-12 | 318.9 | 2024-01-30 | 213.1 |
| 2024-04-11 | 322.2 | 2024-01-29 | 220.0 |
| 2024-04-10 | 317.8 | 2024-01-26 | 226.9 |
| 2024-04-09 | 328.9 | 2024-01-25 | 224.6 |
| 2024-04-08 | 315.6 | 2024-01-24 | 216.2 |
| 2024-04-03 | 326.7 | 2024-01-23 | 211.5 |
| 2024-04-02 | 331.1 | 2024-01-22 | 210.8 |
| 2024-04-01 | 343.3 | 2024-01-19 | 223.8 |
| 2024-03-29 | 336.7 | 2024-01-18 | 226.9 |
| 2024-03-28 | 305.6 | 2024-01-17 | 230.0 |
| 2024-03-27 | 208.5 | 2024-01-16 | 236.9 |
| 2024-03-26 | 213.1 | 2024-01-15 | 239.2 |
| 2024-03-25 | 209.2 | 2024-01-12 | 240.0 |
| 2024-03-22 | 215.4 | 2024-01-11 | 241.5 |
| 2024-03-21 | 221.5 | 2024-01-10 | 239.2 |
| 2024-03-20 | 223.1 | 2024-01-09 | 242.3 |
| 2024-03-19 | 218.5 | 2024-01-08 | 241.5 |
| 2024-03-18 | 222.3 | 2024-01-05 | 246.9 |
| 2024-03-15 | 212.3 | 2024-01-04 | 251.5 |
Realcan Pharmaceutical Group Co Ltd (SZSE:002589) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Realcan Pharmaceutical Group Co Ltd
NAICS : 325412
ISIN : CNE1000013X5
Share Class Description:
SZSE:002589: Class ACompare
Compare
Traded in other countries / regions
002589.China IPO Date
2011-06-10Description
Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers